OncoCyte Corporation

Historical 13F Holders

Symbol
OCX
CUSIP
68235C107
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 1 44.4 k $127 k
2024 Q4 1 47.1 k $112 k
2024 Q3 1 59.4 k $169 k
2024 Q2 2 1.15 M $3.40 M
2024 Q1 2 810 k $2.37 M
2023 Q4 2 826 k $2.05 M
2023 Q3 2 834 k $2.72 M
2023 Q2 48 91.8 M $21.1 M
2023 Q1 53 55.7 M $19.7 M
2022 Q4 61 61.0 M $19.7 M
2022 Q3 67 66.2 M $48.4 M
2022 Q2 79 68.7 M $61.9 M
2022 Q1 91 54.4 M $81.2 M
2021 Q4 98 55.5 M $120 M
2021 Q3 102 56.6 M $202 M
2021 Q2 99 56.6 M $326 M
2021 Q1 95 54.5 M $283 M
2020 Q4 71 32.9 M $78.5 M
2020 Q3 63 31.3 M $43.5 M
2020 Q2 68 33.1 M $63.5 M
2020 Q1 58 27.7 M $67.8 M
2019 Q4 59 26.2 M $58.9 M
2019 Q3 57 19.0 M $39.9 M
2019 Q2 58 16.1 M $40.0 M
2019 Q1 54 16.1 M $63.7 M
2018 Q4 26 8.33 M $11.5 M
2018 Q3 29 8.72 M $21.8 M
2018 Q2 36 8.78 M $22.4 M
2018 Q1 42 8.64 M $18.1 M
2017 Q4 47 4.68 M $21.7 M
2017 Q3 39 4.41 M $33.3 M
2017 Q2 44 3.90 M $20.7 M
2017 Q1 35 3.78 M $22.5 M
2016 Q4 35 3.13 M $22.0 M
2016 Q3 32 3.08 M $15.5 M
2016 Q2 35 1.59 M $5.64 M
2016 Q1 43 1.67 M $7.70 M
2015 Q4 6 1.09 M $6.84 M